Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of adjunctive zonisamide in paediatric partial-onset seizures
2007-000198-53Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of zonisamide in epilepsy and Focal Onset Epilepsy, sponsored by Eisai Co., Ltd. Primary endpoint: Responder rate (≥50% reduction in seizure frequency). Started Apr 2008; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2007-000198-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000198-53.